Hospitalizations, costs, and mortality among infants with critical congenital heart disease: How important is timely detection?
Cora Peterson(National Center on Birth Defects and Developmental Disabilities), Cynthia H. Cassell(Centers for Disease Control and Prevention), Tiffany Riehle‐Colarusso(Centers for Disease Control and Prevention), Scott D. Grosse(National Center for Environmental Health), April L. Dawson(Centers for Disease Control and Prevention), Jean Paul Tanner(Jaeb Center for Health Research), Richard S. Olney(University of Iowa), Russell S. Kirby(University of South Florida), Jane Correia(Florida Department of Health), Sharon Watkins(Florida Department of Health)
Cited by 89
Related Papers
Guidelines for case classification for the national birth defects prevention study
|Birth Defects Research Part A Clinical and Molecular Teratology|2003|582
Sickle Hemoglobin (Hb S) Allele and Sickle Cell Disease: A HuGE Review
|American Journal of Epidemiology|2000|535
Use of Selective Serotonin-Reuptake Inhibitors in Pregnancy and the Risk of Birth Defects
|New England Journal of Medicine|2007|501
Seeking causes: Classifying and evaluating congenital heart defects in etiologic studies
|Birth Defects Research Part A Clinical and Molecular Teratology|2007|464
Vital Signs: Update on Zika Virus–Associated Birth Defects and Evaluation of All U.S. Infants with Congenital Zika Virus Exposure — U.S. Zika Pregnancy Registry, 2016
|MMWR Morbidity and Mortality Weekly Report|2017|299